Observational cohort study on breast cancer treatment in China
A Multicenter Prospective Observational Cohort Study of Breast Cancer Based on a Breast Cancer Medical Record Database in China
This study looks at how breast cancer is treated in different parts of China to see what works best and improve care for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 20000 (estimated) |
| Sex | All |
| Sponsor | Fudan University Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Trial ID | NCT06591039 on ClinicalTrials.gov |
What this trial studies
This study aims to create a prospective, multi-center cohort focused on breast cancer treatment in China. It will analyze various factors influencing breast cancer diagnosis and treatment across different regions and hospitals. The research will also evaluate the effectiveness of current diagnostic and treatment protocols, publish annual reports, and promote clinical guidelines. Additionally, it seeks to establish clinical quality standards and provide a foundation for specialized training programs and health insurance policy formulation.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with malignant breast tumors, including various types of breast carcinoma.
Not a fit: Patients with benign breast conditions or those not diagnosed with malignant tumors may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of breast cancer treatment and improve patient outcomes through better guidelines and standards.
How similar studies have performed: Other studies focusing on observational cohorts in cancer treatment have shown success in improving clinical practices and patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with malignant breast tumors must be diagnosed by cytology or histology, and their pathological types include but are not limited to breast carcinoma in situ, invasive carcinoma, and breast sarcoma. Exclusion Criteria: * None
Where this trial is running
Shanghai, Shanghai Municipality
- Cancer Hospital/ Institute, Fudan University — Shanghai, Shanghai Municipality, China (Recruiting)
Study contacts
- Principal investigator: Jiong Wu, M.D — Cancer Hospital/ Institute, Fudan University
- Study coordinator: Jiong Wu, M.D
- Email: wujiong1122@vip.sina.com
- Phone: +862164175590
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.